Kadmon Holdings Overview

  • Founded
  • 2009
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 127
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 12
  • Investments
  • 4

Kadmon Holdings General Information

Description

Kadmon Holdings Inc is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of small molecules and biologics with a focus on inflammatory and fibrotic diseases. Its pipeline products include Belumosudil (KD025) and KD033.

Contact Information

Website
www.kadmon.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Parent Company
Sanofi
Former Stock Listing
KDMN
Primary Office
  • 450 East 29th Street
  • New York, NY 10016
  • United States
+1 (833) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Kadmon Holdings Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kadmon Holdings‘s full profile, request access.

Request a free trial

Kadmon Holdings Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Kadmon Holdings Inc is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commerciali
Biotechnology
New York, NY
127 As of 2020
00000
0.00 0000-00-00
000000&0 00000

00 00000

elit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, su
0000000000000
Durham, NC
000 As of 0000
00000
000000 - 000 00000

00000000

lor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint
0000000000000
Trevose, PA
00 As of 0000
00000
0000 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Kadmon Holdings Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
G1 Therapeutics Formerly VC-backed Durham, NC 000 00000 000000 - 000 00000
000000000000 00000 Corporate Backed or Acquired Trevose, PA 00 00000 000000&0 00000
00000000 Formerly VC-backed Paris, France 00 000.00 000000000 000.00
0000000 0000000000 Formerly VC-backed New York, NY 00 00000 000000&0 00000
00000 000000000000 Formerly VC-backed Plano, TX 000 00.000 000000000 00.000
You’re viewing 5 of 8 competitors. Get the full list »

Kadmon Holdings Patents

  • 138

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 10

    Granted

  • 4

    Pending

  • 000

    Expiring in next 12 mo

Kadmon Holdings Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200199109-A1 Inhibitors of rho associated coiled-coil containing protein kinase Pending 01-Sep-2017 000000000
JP-2020532549-A Rho-related coiled coil-containing protein kinase inhibitor Pending 01-Sep-2017 0000000000
EP-3675861-A1 Inhibitors of rho associated coiled-coil containing protein kinase Pending 01-Sep-2017 000000000
EP-3675861-A4 Inhibitors of rho associated coiled-coil containing protein kinase Pending 01-Sep-2017 0000000000 0
CA-3073931-A1 Inhibitors of rho associated coiled-coil containing protein kinase Pending 01-Sep-2017 C07D403/12
To view Kadmon Holdings’s complete patent history, request access »

Kadmon Holdings Executive Team (12)

Name Title Board Seat Contact Info
Steven Meehan Chief Financial Officer, Finance & Executive Vice President
Steven Gordon Executive Vice President & Chief Administrative, Compliance and Legal Officer
Eva Heyman Executive Vice President & Chief Commercial Officer
Haya Taitel Chief Commercial Officer & Senior Vice President
You’re viewing 4 of 12 executive team members. Get the full list »

Kadmon Holdings Board Members (17)

Name Representing Role Since
00000 00000000 Self Board Member 000 0000
0000 000000 Self Board Member 000 0000
000000 00000 00 Self Board Member 000 0000
00000 000 Self Board Member 000 0000
00000 0000000 00 Self Board Member 000 0000
You’re viewing 5 of 17 board members. Get the full list »

Kadmon Holdings Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kadmon Holdings Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Kadmon Holdings‘s full profile, request access.

Request a free trial

Kadmon Holdings Investments & Acquisitions (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 0000000 26-Dec-2019 00000 0000 Drug Discovery 000000 00
00 0000000000 07-Nov-2019 00000 0000 Pharmaceuticals 000000 00
00000 000000 25-Oct-2010 0000000000 Pharmaceuticals 000000 00
PhytoCeutica 24-Oct-2010 Merger/Acquisition Biotechnology
To view Kadmon Holdings’s complete investments and acquisitions history, request access »